Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole

Chagas disease remains a major social and public health problem in Latin America. Benznidazole (BZN) is the main drug with activity against Trypanosoma cruzi. Due to the high number of adverse drug reactions (ADRs), BZN is underprescribed. The goal of this study was to evaluate the genetic and trans...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int J Mol Sci
Egile Nagusiak: Franco, Lucas A. M., Moreira, Carlos H. V., Buss, Lewis F., Oliveira, Lea C., Martins, Roberta C. R., Manuli, Erika R., Lindoso, José A. L., Busch, Michael P., Pereira, Alexandre C., Sabino, Ester C.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2021
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7920452/
https://ncbi.nlm.nih.gov/pubmed/33669428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22041960
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak